Richard Scott Shively

Filings by Richard Scott Shively span 3 companies, the busiest being Zogenix, Inc., Depomed Inc and Alpharma Inc. The record holds 9 filings, for trades running from 25 July 2008 to 2 April 2016.

In open-market terms, that means 2 purchases worth €138k on one side and 3 sales worth €30k on the other. Purchases outweigh sales by €108k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants.

The newest entry dates from 5 April 2016: a share grant of €12k, in Depomed Inc. The clock since the last published purchase (21 November 2013) now reads 4,736 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.